medmix AG (MEDX) - Total Liabilities
Based on the latest financial reports, medmix AG (MEDX) has total liabilities worth CHF536.50 Million CHF (≈ $678.28 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore MEDX cash generation efficiency to assess how effectively this company generates cash.
medmix AG - Total Liabilities Trend (2018–2025)
This chart illustrates how medmix AG's total liabilities have evolved over time, based on quarterly financial data. Check MEDX financial resilience to evaluate the company's liquid asset resilience ratio.
medmix AG Competitors by Total Liabilities
The table below lists competitors of medmix AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Industrial Logistics Properties Trust
NASDAQ:ILPT
|
USA | $4.29 Billion |
|
Delta Plus Group SA
PA:ALDLT
|
France | €261.79 Million |
|
Linhai Co Ltd
SHG:600099
|
China | CN¥608.04 Million |
|
Zhubo Design
SHE:300564
|
China | CN¥339.10 Million |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
China | CN¥1.62 Billion |
|
Fittech Co Ltd
TW:6706
|
Taiwan | NT$3.37 Billion |
|
Daeduck Co. Ltd.
KO:008060
|
Korea | ₩338.17 Billion |
|
SGL Carbon SE
XETRA:SGL
|
Germany | €714.90 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down medmix AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of medmix AG.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.54 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how medmix AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for medmix AG (2018–2025)
The table below shows the annual total liabilities of medmix AG from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CHF536.50 Million ≈ $678.28 Million |
+5.71% |
| 2024-12-31 | CHF507.50 Million ≈ $641.62 Million |
-4.68% |
| 2023-12-31 | CHF532.40 Million ≈ $673.10 Million |
-11.43% |
| 2022-12-31 | CHF601.10 Million ≈ $759.95 Million |
+36.46% |
| 2021-12-31 | CHF440.50 Million ≈ $556.91 Million |
-3.50% |
| 2020-12-31 | CHF456.50 Million ≈ $577.14 Million |
+13.59% |
| 2019-12-31 | CHF401.90 Million ≈ $508.11 Million |
+6.21% |
| 2018-12-31 | CHF378.40 Million ≈ $478.40 Million |
-- |
About medmix AG
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through Healthcare; and Consumer and Industrial segments. The company offers dental products, including mixing tips and cartridges for various applications, such as prosthetics, restorations, anesthetics, and aesthetics; drug delivery devices that are used to inject fertility… Read more